Attenuated beta endorphin response to acute stress is associated with smoking relapse

[1]  R. Carelli,et al.  The Nucleus Accumbens and Pavlovian Reward Learning , 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[2]  T. Friedman,et al.  Repeated stress alters the ability of nicotine to activate the hypothalamic–pituitary–adrenal axis , 2006, Journal of neurochemistry.

[3]  K. Berridge,et al.  Hedonic Hot Spot in Nucleus Accumbens Shell: Where Do μ-Opioids Cause Increased Hedonic Impact of Sweetness? , 2005, The Journal of Neuroscience.

[4]  B. Budzyńska,et al.  Naloxone precipitates nicotine abstinence syndrome and attenuates nicotine-induced antinociception in mice. , 2005, Pharmacological reports : PR.

[5]  Richard A. Brown,et al.  Distress tolerance and early smoking lapse. , 2005, Clinical psychology review.

[6]  J. Blendy,et al.  μ-Opioid Receptor and CREB Activation Are Required for Nicotine Reward , 2005, Neuron.

[7]  M. al’Absi,et al.  Attenuated adrenocorticotropic responses to psychological stress are associated with early smoking relapse , 2005, Psychopharmacology.

[8]  F. Weiss.  Neurobiology of craving, conditioned reward and relapse. , 2005, Current opinion in pharmacology.

[9]  K. Lynch,et al.  Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm , 2005, Psychopharmacology.

[10]  N. Rigotti,et al.  Smoking behavior and interest in quitting among homeless smokers. , 2004, Addictive behaviors.

[11]  G. Wand,et al.  Opioids and alcoholism , 2004, Physiology & Behavior.

[12]  A. King,et al.  Naltrexone attenuates acute cigarette smoking behavior , 2004, Pharmacology Biochemistry and Behavior.

[13]  A. Zangen,et al.  Effect of experimenter‐delivered and self‐administered cocaine on extracellular β‐endorphin levels in the nucleus accumbens , 2003, Journal of neurochemistry.

[14]  J. Kassel,et al.  Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking. , 2003, Psychological bulletin.

[15]  M. al’Absi,et al.  Attenuated adrenocortical and blood pressure responses to psychological stress in ad libitum and abstinent smokers , 2003, Pharmacology Biochemistry and Behavior.

[16]  R. Maldonado,et al.  Attenuation of Nicotine-Induced Antinociception, Rewarding Effects, and Dependence in μ-Opioid Receptor Knock-Out Mice , 2002, The Journal of Neuroscience.

[17]  M. Piasecki,et al.  An Exploratory Study: The Use of Paroxetine for Methamphetamine Craving , 2002, Journal of psychoactive drugs.

[18]  Mustafa al'Absi,et al.  Adrenocortical and hemodynamic predictors of pain perception in men and women , 2002, Pain.

[19]  D. Wetter,et al.  Predicting relapse back to smoking: contrasting affective and physical models of dependence. , 2002, Journal of consulting and clinical psychology.

[20]  K. Nader,et al.  Motivational state determines the functional role of the mesolimbic dopamine system in the mediation of opiate reward processes , 2002, Behavioural Brain Research.

[21]  C. Hodge,et al.  Stimulation of Endorphin Neurotransmission in the Nucleus Accumbens by Ethanol, Cocaine, and Amphetamine , 2001, The Journal of Neuroscience.

[22]  M. Zvolensky,et al.  Anxiety sensitivity: relationship to negative affect smoking and smoking cessation in smokers with past major depressive disorder. , 2001, Addictive behaviors.

[23]  C. Gianoulakis.  Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism. , 2001, Journal of psychiatry & neuroscience : JPN.

[24]  L. Cox,et al.  Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. , 2001, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[25]  C. Wilkinson,et al.  Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis. , 2000, Alcoholism, clinical and experimental research.

[26]  M. T. Miranda,et al.  Plasma concentrations of beta-endorphin in smokers who consume different numbers of cigarettes per day , 2000, Pharmacology Biochemistry and Behavior.

[27]  P. Meyer,et al.  Naltrexone Alteration of Acute Smoking Response in Nicotine-Dependent Subjects , 2000, Pharmacology Biochemistry and Behavior.

[28]  L. Covey.  Tobacco cessation among patients with depression. , 1999, Primary care.

[29]  M. Rosen,et al.  Naloxone challenge in smokers. Preliminary evidence of an opioid component in nicotine dependence. , 1999, Archives of general psychiatry.

[30]  Mitsuo Nakamura,et al.  Neural systems for behavioral activation and reward , 1999, Current Opinion in Neurobiology.

[31]  F. Weiss,et al.  Suppression of Ethanol-Reinforced Behavior by Naltrexone Is Associated with Attenuation of the Ethanol-Induced Increase in Dialysate Dopamine Levels in the Nucleus Accumbens , 1998, The Journal of Neuroscience.

[32]  Michael F. Wilson,et al.  Hypothalamic-Pituitary-Adrenocortical Responses to Psychological Stress and Caffeine in Men at High and Low Risk for Hypertension , 1998, Psychosomatic medicine.

[33]  E. Nestler,et al.  Relapse to drug-seeking: neural and molecular mechanisms. , 1998, Drug and alcohol dependence.

[34]  D. Rasmussen.  EFFECTS OF CHRONIC NICOTINE TREATMENT AND WITHDRAWAL ON HYPOTHALAMIC PROOPIOMELANOCORTIN GENE EXPRESSION AND NEUROENDOCRINE REGULATION , 1998, Psychoneuroendocrinology.

[35]  O. Pomerleau.  Endogenous opioids and smoking: A review of progress and problems , 1998, Psychoneuroendocrinology.

[36]  C. Marchesi,et al.  Beta-endorphin, adrenocorticotropic hormone and cortisol secretion in abstinent alcoholics , 1997, Psychiatry Research.

[37]  G F Koob,et al.  Drug abuse: hedonic homeostatic dysregulation. , 1997, Science.

[38]  D. Sarkar,et al.  The secretory response of hypothalamic beta-endorphin neurons to acute and chronic nicotine treatments and following nicotine withdrawal. , 1997, Life sciences.

[39]  J Licinio,et al.  Cardiovascular and neuroendocrine adjustment to public speaking and mental arithmetic stressors. , 1997, Psychophysiology.

[40]  E. Strauss,et al.  Validity of the paced auditory serial addition test (pasat) in adults referred for neuropsychological assessment after head injury , 1997 .

[41]  M. M. Ward,et al.  Abstinence effects as predictors of 28-day relapse in smokers. , 1996, Addictive behaviors.

[42]  A. Heinz,et al.  Hypothalamic-pituitary-gonadal axis, prolactin, and cortisol in alcoholics during withdrawal and after three weeks of abstinence: comparison with healthy control subjects , 1995, Psychiatry Research.

[43]  T. Svensson,et al.  Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release. , 1994, Pharmacology & toxicology.

[44]  M. E. Wewers,et al.  Plasma nicotine, plasma β-endorphin and mood states during periods of chronic smoking, abstinence and nicotine replacement , 1994, Psychopharmacology.

[45]  M. al’Absi,et al.  Borderline hypertensives produce exaggerated adrenocortical responses to mental stress. , 1994, Psychosomatic medicine.

[46]  J. Salamone.  The involvement of nucleus accumbens dopamine in appetitive and aversive motivation , 1994, Behavioural Brain Research.

[47]  P. Robledo,et al.  Two discrete nucleus accumbens projection areas differentially mediate cocaine self-administration in the rat , 1993, Behavioural Brain Research.

[48]  K. Grant,et al.  Proopiomelanocortin messenger RNA is decreased in the mediobasal hypothalamus of rats made dependent on ethanol. , 1992, Alcoholism, clinical and experimental research.

[49]  J. Hughes.  Tobacco withdrawal in self-quitters. , 1992, Journal of consulting and clinical psychology.

[50]  O. Pomerleau.  Nicotine and the central nervous system: biobehavioral effects of cigarette smoking. , 1992, The American journal of medicine.

[51]  B. Rosner,et al.  Predictors of smoking relapse among self-quitters: a report from the Normative Aging Study. , 1992, Addictive behaviors.

[52]  K. Perkins,et al.  Increased desire to smoke during acute stress. , 1992, British journal of addiction.

[53]  G. Koob.  Neural Mechanisms of Drug Reinforcement a , 1992, Annals of the New York Academy of Sciences.

[54]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[55]  P. Kalivas,et al.  Autoradiographic localization of μ-opioid and neurotensin receptors within the mesolimbic dopamine system , 1989, Brain Research.

[56]  M. E. Lewis,et al.  Anatomy of CNS opioid receptors , 1988, Trends in Neurosciences.

[57]  D. Hatsukami,et al.  Symptoms of tobacco withdrawal from total cigarette cessation versus partial cigarette reduction , 1988, Psychopharmacology.

[58]  R. Smith,et al.  Opioid peptides in blood and cerebrospinal fluid during acute stress. , 1987, Bailliere's clinical endocrinology and metabolism.

[59]  R. Smith,et al.  Acute hemorrhagic stress in conscious sheep elevates immunoreactive beta-endorphin in plasma but not in cerebrospinal fluid. , 1986, Endocrinology.

[60]  H. Akil,et al.  β‐Endorphin/ACTH immunocytochemistry in the CNS of the lizard Anolis carolinensis: Evidence for a major mesencephalic cell group , 1984, The Journal of comparative neurology.

[61]  T. Kamarck,et al.  A global measure of perceived stress. , 1983, Journal of health and social behavior.

[62]  F. Bloom,et al.  beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. , 1977, Science.

[63]  D. Gronwall.  Paced Auditory Serial-Addition Task: A Measure of Recovery from Concussion , 1977, Perceptual and motor skills.

[64]  W. Pritchard,et al.  Enhancement of continuous performance task reaction time by smoking in non-deprived smokers , 2005, Psychopharmacology.

[65]  C. Gianoulakis.  Endogenous opioids and addiction to alcohol and other drugs of abuse. , 2004, Current topics in medicinal chemistry.

[66]  C. Elwin,et al.  The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers , 2004, European Journal of Clinical Pharmacology.

[67]  D. Kooy,et al.  Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area , 2003, Molecular Psychiatry.

[68]  A. Herz.  Endogenous opioid systems and alcohol addiction , 1997, Psychopharmacology.

[69]  Sheldon Cohen,et al.  Perceived stress, quitting smoking, and smoking relapse. , 1990, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[70]  M. Stitzer,et al.  Smoking relapse: the role of pharmacological and behavioral factors. , 1988, Progress in clinical and biological research.

[71]  L. Radloff.  The CES-D Scale: A Self-Report Depression Scale for Research in the General Population — Source link , 2022 .